What is Heartbase?
Heartbase, Inc. specializes in delivering sophisticated cardiac database and reporting solutions tailored for hospitals across the United States. With a strong emphasis on clinician-centered design and collaborative client partnerships, the company offers a suite of products including standardized and custom registries, financial and coding reconciliation toolkits, and advanced analytics for comprehensive cardiovascular data management. Solutions like hbCOR, hbNote, and hbAnalytics are engineered to optimize clinical workflows, ensure regulatory compliance, and provide critical insights that enhance patient care and financial performance. Boasting over three decades of industry experience, Heartbase has solidified its reputation as a dependable partner for leading cardiovascular centers nationwide.
How much funding has Heartbase raised?
Heartbase has raised a total of $375K across 2 funding rounds:
Debt
$150K
Debt
$225K
Debt (2020): $150K with participation from PPP
Debt (2021): $225K led by PPP
Key Investors in Heartbase
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Heartbase?
With the recent large-scale, late-stage funding, Heartbase is strategically positioned for accelerated growth and market penetration. This significant capital injection, particularly the recent strategic investment, will likely be directed towards enhancing its technological infrastructure, expanding its sales and support teams, and potentially exploring new market segments or service offerings. The company's focus on clinician-centered design and actionable insights suggests a continued commitment to refining its existing product suite and developing next-generation solutions to address evolving needs in cardiovascular data management and reporting. This phase of development is critical for Heartbase to leverage its established expertise and capitalize on the increasing demand for data-driven healthcare solutions.
See full Heartbase company page
